APA (7th ed.) Citation

S, G., & T, P. (2026). EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic viruses. Cancer immunology, immunotherapy : CII, 75(7), . https://doi.org/10.1007/s00262-026-04470-4

Chicago Style (17th ed.) Citation

S, Gahbauer, and Poiret T. "EGFRxCD16 Bispecific Antibodies Orchestrate Superior NK Cell-mediated Lysis of Ovarian Cancer and NSCLC Cell Lines in Combination with Oncolytic Viruses." Cancer Immunology, Immunotherapy : CII 75, no. 7 (2026). https://doi.org/10.1007/s00262-026-04470-4.

MLA (9th ed.) Citation

S, Gahbauer, and Poiret T. "EGFRxCD16 Bispecific Antibodies Orchestrate Superior NK Cell-mediated Lysis of Ovarian Cancer and NSCLC Cell Lines in Combination with Oncolytic Viruses." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 7, 2026, https://doi.org/10.1007/s00262-026-04470-4.